Mobile Edition
Print
Get the Mag
Weekly UpdatesMillennium Pharmaceuticals, Inc. (Cambridge, MA) has patented antibodies or antigen-binding fragments thereof which binds the chemokine mammalian TECK and inhibit binding of the chemokine to mammalian GPR-9-6. The invention also relates to host cells that produce such antibodies or antigen-binding fragments, kits comprising such antibodies or antigen-binding fragments and methods of use for such antibodies and antigen-binding fragments. (US 7,381,412)
|
More Resources
|
|||
Millennium Pharmaceuticals obtains United States patent.
COPYRIGHT 2008 Biotech Patent
News Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2008 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company. NOTE: All illustrations and photos have been removed from this article. |
|||
FEED